Share this article
Share this article
ALBANY, N.Y., April 1, 2021 /PRNewswire/ The widespread utilization of cerebral somatic oximeters in both non-hemostasis and hemostasis applications is likely to propel the growth of the global cerebral somatic oximeters market in the years to come. In addition to that, the increasing utilisation of cerebral somatic oximeters by various end users such as ambulatory surgical centres, hospitals, and clinics is estimated to bode well for the said market in the years to come. Less oxygen supply to the brain induces neurological disorders and brain damage conditions including hypoxic-ischemic encephalopathy (HIE). As a result, demand for cerebral oximeters is expected to rise as the incidence of cerebral hypoxia increases.